BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26797018)

  • 21. Currently available antitussives.
    Dicpinigaitis PV
    Pulm Pharmacol Ther; 2009 Apr; 22(2):148-51. PubMed ID: 18771744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experience with Baby-Liberol, a percutaneous expectorant, in infants and small children].
    Hanker H
    Z Allgemeinmed; 1969 Feb; 45(6):268-9. PubMed ID: 5801647
    [No Abstract]   [Full Text] [Related]  

  • 23. Mucoactive drugs and multiple applications in pulmonary disease therapy.
    Hocquigny A; Hugerot H; Ghanem R; Haute T; Laurent V; Cogulet V; Montier T
    Eur J Pharm Biopharm; 2024 Jan; 194():110-117. PubMed ID: 38048888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erdosteine: antitussive and anti-inflammatory effects.
    Dal Negro RW
    Lung; 2008; 186 Suppl 1():S70-3. PubMed ID: 18185958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of Ascoril expectorant and other cough formula in the treatment of cough management in paediatric and adult patients--a randomised double-blind comparative trial.
    Jayaram S; Desai A
    J Indian Med Assoc; 2000 Feb; 98(2):68-70. PubMed ID: 11016157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The new possibility for the treatment of acute cough].
    Klyachkina IL
    Vestn Otorinolaringol; 2015; 80(5):85-90. PubMed ID: 26525480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the efficacy of mucoactive aerosol therapy.
    Fuloria M; Rubin BK
    Respir Care; 2000 Jul; 45(7):868-73. PubMed ID: 10926385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucolytics, expectorants, and mucokinetic medications.
    Rubin BK
    Respir Care; 2007 Jul; 52(7):859-65. PubMed ID: 17594730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of mucoactive agents in the mechanically ventilated patient: a review of the literature.
    Icard BL; Rubio E
    Expert Rev Respir Med; 2017 Oct; 11(10):807-814. PubMed ID: 28737047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for adjunctive symptom relief of acute respiratory infections.
    Kikano G
    Postgrad Med; 2009 May; 121(3):173-5. PubMed ID: 19491556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Other mucoactive agents for cystic fibrosis.
    Bye PT; Elkins MR
    Paediatr Respir Rev; 2007 Mar; 8(1):30-9. PubMed ID: 17419976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?
    Scaglione F; Petrini O
    Clin Med Insights Ear Nose Throat; 2019; 12():1179550618821930. PubMed ID: 30670922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections.
    LaForce C; Gentile DA; Skoner DP
    Postgrad Med; 2008 Jul; 120(2):53-9. PubMed ID: 18654069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respiratory-related quality of life: relation to pulmonary function, functional exercise capacity, and sputum biophysical properties.
    Piquette CA; Clarkson L; Okamoto K; Kim JS; Rubin BK
    J Aerosol Med; 2000; 13(3):263-72. PubMed ID: 11066029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rengalin, a novel drug for treatment of cough in children. Intermediate data on multicentre, comparative randomized clinical trial].
    Geppe NA; Kondyurina EG; Galustyan AN; Pak TE; Baltserovich NB; Zhiglinskaya OV; Kamaev AV; Lazareva SG; Laleko SL; Melnikova IM; Mikhalkova EV; Perminova OA; Sabitov AU; Spivakovsky YM
    Antibiot Khimioter; 2014; 59(7-8):16-24. PubMed ID: 25975103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerosol Medications for Treatment of Mucus Clearance Disorders.
    Rubin BK
    Respir Care; 2015 Jun; 60(6):825-9; discussion 830-32. PubMed ID: 26070577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current drugs for the treatment of dry cough.
    Padma L
    J Assoc Physicians India; 2013 May; 61(5 Suppl):9-13. PubMed ID: 24490443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
    Crisafulli E; Coletti O; Costi S; Zanasi E; Lorenzi C; Lucic S; Fabbri LM; Bertini M; Clini EM
    Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of cough in acute respiratory virus infections and influenza by the patients of risk group].
    Kliachkina IL
    Voen Med Zh; 2009 Jul; 330(7):40-5. PubMed ID: 19827667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benylin expectorant versus actifed expectorant in the treatment of acute cough.
    Jaffe GV; Grimshaw JJ
    Br J Clin Pract; 1985 Jun; 39(6):238-42. PubMed ID: 4041350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.